Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,986 | 182 | 50.5% |
| Consulting Fee | $2,748 | 3 | 23.2% |
| Long term medical supply or device loan | $1,196 | 12 | 10.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $967.50 | 1 | 8.2% |
| Travel and Lodging | $692.67 | 3 | 5.8% |
| Education | $269.99 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $2,568 | 11 | $0 (2024) |
| Genentech USA, Inc. | $1,521 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,453 | 27 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $967.50 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $433.59 | 11 | $0 (2024) |
| Incyte Corporation | $395.11 | 6 | $0 (2024) |
| PFIZER INC. | $359.13 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $353.03 | 5 | $0 (2024) |
| ABBVIE INC. | $295.79 | 11 | $0 (2024) |
| GENZYME CORPORATION | $250.36 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,212 | 140 | Regeneron Pharmaceuticals, Inc. ($2,568) |
| 2023 | $1,441 | 42 | AstraZeneca Pharmaceuticals LP ($207.42) |
| 2022 | $965.22 | 17 | Myriad Genetic Laboratories, Inc. ($168.48) |
| 2021 | $242.46 | 5 | PUMA BIOTECHNOLOGY, INC. ($125.00) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.58 | General |
| 12/18/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $99.33 | General |
| 12/11/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $107.58 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Oncology | ||||||
| 11/18/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $18.34 | General |
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 11/12/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $41.91 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $127.40 | General |
| Category: Hematology/Oncology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $132.12 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Rare Disease | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Oncology | ||||||
| 10/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $34.73 | General |
| 10/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 146 | 170 | $66,241 | $13,420 |
| 2022 | 5 | 229 | 254 | $78,137 | $16,011 |
| 2021 | 5 | 334 | 449 | $104,436 | $29,150 |
| 2020 | 12 | 699 | 7,798 | $201,996 | $48,616 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 118 | $45,831 | $9,289 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $12,100 | $2,484 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $8,310 | $1,646 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 132 | $49,968 | $9,895 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 34 | $17,680 | $3,587 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 28 | $7,161 | $1,355 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 14 | $2,254 | $880.60 | 39.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 33 | 33 | $957.00 | $254.49 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 13 | $117.00 | $39.00 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 233 | $65,706 | $18,223 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 127 | $24,384 | $6,551 | 26.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 35 | $13,300 | $4,080 | 30.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 28 | 28 | $812.00 | $217.56 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 26 | 26 | $234.00 | $78.00 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 196 | 337 | $95,034 | $22,395 | 23.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 69 | 86 | $32,680 | $7,536 | 23.1% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2020 | 11 | 6,630 | $13,260 | $5,355 | 40.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 113 | $21,696 | $5,188 | 23.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 22 | 36 | $14,868 | $2,789 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 42 | $7,980 | $1,981 | 24.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 100 | 146 | $4,234 | $1,121 | 26.5% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 18 | 45 | $4,635 | $834.16 | 18.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 17 | 19 | $3,553 | $704.47 | 19.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 93 | 134 | $1,206 | $397.44 | 33.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 24 | 40 | $2,680 | $299.52 | 11.2% |
About Sandra Garofalo, APRN
Sandra Garofalo, APRN is a Nurse Practitioner healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1689221905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Garofalo, APRN has received a total of $11,860 in payments from pharmaceutical and medical device companies, with $9,212 received in 2024. These payments were reported across 204 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,986).
As a Medicare-enrolled provider, Garofalo has provided services to 1,408 Medicare beneficiaries, totaling 8,671 services with total Medicare billing of $107,197. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Gerontology
- Location Indianapolis, IN
- Active Since 08/21/2019
- Last Updated 12/02/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1689221905
Products in Payments
- Venclexta (Biological) $1,350
- KISQALI (Drug) $1,280
- JAKAFI (Drug) $277.40
- OPDIVO (Biological) $259.18
- REBLOZYL (Biological) $185.59
- KEYTRUDA (Biological) $174.67
- myRisk (Device) $168.48
- SARCLISA (Biological) $167.29
- VENCLEXTA (Drug) $164.78
- TUKYSA (Drug) $151.55
- IMFINZI (Biological) $134.34
- EPKINLY (Drug) $131.01
- LUMAKRAS (Drug) $131.00
- Lenvima (Drug) $128.60
- NERLYNX (Drug) $125.00
- XPOVIO (Drug) $125.00
- ADCETRIS (Biological) $123.99
- TECENTRIQ (Biological) $118.91
- AYVAKIT (Drug) $114.58
- Blincyto (Biological) $107.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Indianapolis
Kristi Orbaugh, Np, NP
Nurse Practitioner — Payments: $1.1M
Ms. Kacy Rogers, Np, NP
Nurse Practitioner — Payments: $42,515
Jennifer Maahs, Np, NP
Nurse Practitioner — Payments: $35,512
Brittany Savage, Agpcnp, AGPCNP
Nurse Practitioner — Payments: $34,832
Dr. Dawn Stepp, Np, NP
Nurse Practitioner — Payments: $30,745
Angela Pierce, Np, NP
Nurse Practitioner — Payments: $18,010